EMA Authorised: Hemangiol (propranolol hydrochloride) — Pierre Fabre Medicament

View source ↗

Summary

Hemangiol, containing propranolol hydrochloride, has been authorised in Europe for treatment of hemangioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemangioma

Drugs mentioned

• Hemangiol (propranolol)

Snippet

Status: Authorised. Therapeutic area: Hemangioma. MAH: Pierre Fabre Medicament. Decision date: 10/01/2023